Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3521 | 1888 | 43.8 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
295 | 18105 | FANCONI ANEMIA//ATAXIA TELANGIECTASIA//WERNER SYNDROME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FANCONI ANEMIA | Author keyword | 590 | 73% | 24% | 451 |
2 | FANCONI ANAEMIA | Author keyword | 86 | 67% | 4% | 78 |
3 | FANCD2 | Author keyword | 76 | 81% | 2% | 46 |
4 | FANCONIS ANEMIA | Author keyword | 57 | 65% | 3% | 54 |
5 | FANCA | Author keyword | 55 | 92% | 1% | 22 |
6 | HUMAN GENET HEMATOL | Address | 48 | 76% | 2% | 34 |
7 | FANCONIS ANAEMIA | Author keyword | 31 | 76% | 1% | 22 |
8 | CLIN GENET HUMAN GENET | Address | 21 | 35% | 3% | 50 |
9 | FANCG | Author keyword | 21 | 85% | 1% | 11 |
10 | FANCM | Author keyword | 17 | 79% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FANCONI ANEMIA | 590 | 73% | 24% | 451 | Search FANCONI+ANEMIA | Search FANCONI+ANEMIA |
2 | FANCONI ANAEMIA | 86 | 67% | 4% | 78 | Search FANCONI+ANAEMIA | Search FANCONI+ANAEMIA |
3 | FANCD2 | 76 | 81% | 2% | 46 | Search FANCD2 | Search FANCD2 |
4 | FANCONIS ANEMIA | 57 | 65% | 3% | 54 | Search FANCONIS+ANEMIA | Search FANCONIS+ANEMIA |
5 | FANCA | 55 | 92% | 1% | 22 | Search FANCA | Search FANCA |
6 | FANCONIS ANAEMIA | 31 | 76% | 1% | 22 | Search FANCONIS+ANAEMIA | Search FANCONIS+ANAEMIA |
7 | FANCG | 21 | 85% | 1% | 11 | Search FANCG | Search FANCG |
8 | FANCM | 17 | 79% | 1% | 11 | Search FANCM | Search FANCM |
9 | FANCC | 15 | 77% | 1% | 10 | Search FANCC | Search FANCC |
10 | FANCONI | 11 | 60% | 1% | 12 | Search FANCONI | Search FANCONI |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FACC | 151 | 95% | 3% | 52 |
2 | MONOUBIQUITINATED FANCD2 | 131 | 87% | 3% | 65 |
3 | NUCLEAR COMPLEX | 108 | 68% | 5% | 95 |
4 | FANCG XRCC9 | 94 | 97% | 1% | 28 |
5 | FANCD2 | 81 | 73% | 3% | 61 |
6 | CROSS LINK REPAIR | 76 | 44% | 7% | 131 |
7 | INDUCED APOPTOTIC RESPONSES | 69 | 96% | 1% | 22 |
8 | BRCA PATHWAY | 63 | 83% | 2% | 35 |
9 | ANEMIA CORE COMPLEX | 55 | 82% | 2% | 32 |
10 | GROUP A GENE | 46 | 59% | 3% | 51 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Fanconi anaemia and the repair of Watson and Crick DNA crosslinks | 2013 | 106 | 74 | 68% |
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins | 2007 | 386 | 101 | 74% |
How the Fanconi Anemia Pathway Guards the Genome | 2009 | 238 | 155 | 76% |
Why does the bone marrow fail in Fanconi anemia? | 2014 | 19 | 87 | 71% |
The Fanconi Anemia DNA Repair Pathway: Structural and Functional Insights into a Complex Disorder | 2014 | 17 | 121 | 76% |
Molecular pathogenesis of Fanconi anemia: recent progress | 2006 | 204 | 135 | 79% |
Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway | 2012 | 133 | 179 | 41% |
DNA interstrand crosslink repair and cancer | 2011 | 196 | 157 | 36% |
The emerging genetic and molecular basis of Fanconi anaemia | 2001 | 334 | 106 | 79% |
Fanconi anaemia: genetics, molecular biology, and cancer-implications for clinical management in children and adults | 2015 | 1 | 91 | 86% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN GENET HEMATOL | 48 | 76% | 1.8% | 34 |
2 | CLIN GENET HUMAN GENET | 21 | 35% | 2.6% | 50 |
3 | DNA DAMAGE SIGNALING | 12 | 48% | 1.0% | 19 |
4 | GENOME MAINTENANCE | 10 | 57% | 0.6% | 12 |
5 | LATE EFFECTS STUDIES | 7 | 53% | 0.5% | 9 |
6 | GRP MUTAGENESIS | 5 | 40% | 0.5% | 10 |
7 | CELLULAR MOL RADIAT ONCOL | 4 | 47% | 0.4% | 7 |
8 | LATE EFFECT STUDIES | 4 | 38% | 0.5% | 9 |
9 | DNA DAMAGE SIGNALINGSAKYO KU | 4 | 75% | 0.2% | 3 |
10 | GRP GENOME ABIL DNA REPAIR | 4 | 75% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000096585 | DYSKERATOSIS CONGENITA//HOYERAAL HREIDARSSON SYNDROME//DYSKERIN |
2 | 0.0000072012 | CHEK2//PALB2//SERV CIRUGIA GEN ESPECIALIDADES |
3 | 0.0000072003 | RAD51//HOMOLOGOUS RECOMBINATION//RAD52 |
4 | 0.0000068442 | TRANSLESION SYNTHESIS//DNA POLYMERASE ETA//DNA DAMAGE TOLERANCE |
5 | 0.0000066590 | WERNER SYNDROME//ROTHMUND THOMSON SYNDROME//RECQ |
6 | 0.0000056274 | OLAPARIB//SYNTHETIC LETHALITY//PARP INHIBITOR |
7 | 0.0000044312 | XERODERMA PIGMENTOSUM//COCKAYNE SYNDROME//NUCLEOTIDE EXCISION REPAIR |
8 | 0.0000040799 | SHWACHMAN DIAMOND SYNDROME//SBDS//SHWACHMAN SYNDROME |
9 | 0.0000039946 | NIJMEGEN BREAKAGE SYNDROME//53BP1//NBS1 |
10 | 0.0000037547 | APLASTIC ANEMIA//SEVERE APLASTIC ANEMIA//APLASTIC ANAEMIA |